Low-Molecular–Weight Heparin versus Unfractionated Heparin in Pregnant Women with Recurrent Abortion associated with Antiphospholipid Syndrome

Aspirin versus low molecular weight heparin for secondary prevention of venous thromboembolism in pregnancy

Therapeutic versus Prophylactic Anticoagulation with Low Molecular Weight Heparin for Moderate COVID-19 Patients

Low molecular weight heparin versus unfractionated heparin in thrombosis prophylaxis after surgical intervention assessed by radionuclide phlebography

Role of low molecular weight of heparin in preventing severe preeclampsia

Prevalence and Prognostic Significance of Deep Venous Thrombosis in Pulmonary Embolism

Predictors of Short-Term Mortality in Patients with Acute Pulmonary Embolism

Assessment of Clinical and Investigations Probabilities for Pulmonary Embolism

Evaluation of Prophylaxis and Management of Venous Thromboembolism in Surgical Cancer Patients

EFFECTIVENESS OF THROMBOLYTIC THERAPY FOR MASSIVE PULMONARY EMBOLISM